336 related articles for article (PubMed ID: 907417)
1. [Treatment of Parkinson's syndrome with a combination of levodopa and carbidopa].
Lombardo L; De la Garza R
Arch Invest Med (Mex); 1977; 8(2):123-8. PubMed ID: 907417
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of Parkinson's disease with levodopa and a dopa decarboxylase inhibitor].
Londoõ R
Neurol Neurocir Psiquiatr; 1976; 17(4):293-300. PubMed ID: 1018729
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of Parkinson's syndrome with L-dopa and L-carbidopa (author's transl)].
Hanzal F
MMW Munch Med Wochenschr; 1976 May; 118(20):653-6. PubMed ID: 818540
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of Parkinson's disease with the combination drug L-carbidopa/L-dopa. Report on a 2 years study].
Hayek J
Schweiz Med Wochenschr; 1977 Apr; 107(14):474-9. PubMed ID: 847450
[TBL] [Abstract][Full Text] [Related]
5. L-dopa-carbidopa: combined therapy for the treatment of Parkinson's disease.
Celesia GG; Wanamaker WM
Dis Nerv Syst; 1976 Mar; 37(3):123-5. PubMed ID: 1253661
[TBL] [Abstract][Full Text] [Related]
6. [The combined treatment of Parkinson's disease with L-dopa plus decarboxylase inhibitors (carbidopa, benserazide) (author's transl)].
Podiwinsky F; Mentasti M; Riederer P; Birkmayer W
Wien Klin Wochenschr; 1979 May; 91(10):332-7. PubMed ID: 452602
[TBL] [Abstract][Full Text] [Related]
7. The effects of combining carbidopa with levodopa for Parkinson's disease.
Martin WE; Tolosa ES; Loewenson RB; Lee MC; Resch JA; Baker AB
Geriatrics; 1975 Dec; 30(12):39-44. PubMed ID: 1104406
[No Abstract] [Full Text] [Related]
8. Comparative study of selegiline plus L-dopa-carbidopa versus L-dopa-carbidopa alone in the treatment of Parkinson's disease.
Brannan T; Yahr MD
Ann Neurol; 1995 Jan; 37(1):95-8. PubMed ID: 7818264
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA.
Pahwa R; Koller WC
Adv Neurol; 1996; 69():487-91. PubMed ID: 8615169
[No Abstract] [Full Text] [Related]
10. Amantadine and a fixed combination of levodopa and carbidopa in the treatment of Parkinson's disease.
Savery F
Dis Nerv Syst; 1977 Aug; 38(8):605-8. PubMed ID: 328244
[TBL] [Abstract][Full Text] [Related]
11. Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa.
Gawel M; Riopelle R; Libman I; Bouchard S
Adv Neurol; 1987; 45():535-8. PubMed ID: 3548263
[No Abstract] [Full Text] [Related]
12. Amantadine and a fixed combination of carbidopa and levodopa in parkinsonism: a preliminary report.
Savery F
Curr Ther Res Clin Exp; 1976 Mar; 19(3):337-8. PubMed ID: 817863
[No Abstract] [Full Text] [Related]
13. Comparison of enteric-coated levodopa with levodopa-carbidopa combination. A double-blind crossover trial.
Gilligan B; Wodak J; Stark R; O'Halloran M
Med J Aust; 1979 Aug; 2(4):205-7. PubMed ID: 390336
[TBL] [Abstract][Full Text] [Related]
14. [CB 154 in the treatment of Parkinson's disease. Results in combination with L-dopa and decarboxylase inhibitor].
Meco G; Casacchia M; Zamponi A; Agnoli A
Acta Neurol (Napoli); 1976; 31(4):479-48. PubMed ID: 1037427
[No Abstract] [Full Text] [Related]
15. [Treatment of Parkinson's syndromes by a combination of levodopa with decarboxylase inhibitors].
Hanzal F
Cesk Neurol Neurochir; 1975 Dec; 38(6):327-32. PubMed ID: 1192544
[No Abstract] [Full Text] [Related]
16. Sinemet CR for Parkinson's disease.
Med Lett Drugs Ther; 1991 Oct; 33(854):92-3. PubMed ID: 1895993
[No Abstract] [Full Text] [Related]
17. The long-term effects of combining carbidopa with levodopa for Parkinson's disease.
Lee MC; Lippert DM; Loewenson RB; Tolosa ES; Resch JA; Martin WE
Trans Am Neurol Assoc; 1976; 101():262-4. PubMed ID: 829295
[No Abstract] [Full Text] [Related]
18. Patient benefits of l-dopa and a decarboxylase inhibitor in the treatment of Parkinson's disease in elderly patients.
Admani AK; Verma S; Cordingley GJ; Harris RI
Pharmatherapeutica; 1985; 4(2):132-40. PubMed ID: 4059292
[TBL] [Abstract][Full Text] [Related]
19. Sinemet CR in Parkinson's disease.
Pfeiffer RF; Wilken KE; Glaeske CS; Hofman R
Nebr Med J; 1991 Jan; 76(1):8-10. PubMed ID: 1997878
[TBL] [Abstract][Full Text] [Related]
20. Response to Sinemet 25/100 in Parkinson's disease.
Ulm G; Gerdes U; Lehmann K
Adv Neurol; 1984; 40():541-7. PubMed ID: 6695634
[No Abstract] [Full Text] [Related]
[Next] [New Search]
